Ireland set to order another 10 million doses of Covid-19 vaccine

Moderna vaccine

"We are also negotiating with AstraZeneca for the possible purchase of another (one) million doses of vaccines", Galvez said.

The BioNTech and Pfizer is also one of Australia's top vaccine candidates, with the government purchasing 10 million doses with the option to purchase more when supply is available.

Ireland, with roughly 1.1% of the EU's population, stands to receive around three million doses of the Pfizer vaccine and roughly 1.6 million doses of the Moderna vaccine after the European Union came close to finalizing a deal with Moderna that could potentially secure 160 million doses.

The initial two million doses that were to be given to Ireland were arriving courtesy of Pfizer, who were the first pharmaceutical company to announce successful trials of a vaccine for coronavirus earlier this month.

The DHSC said the United Kingdom was the first country in the world to sign an agreement with Oxford University/AstraZeneca, securing access to 100 million doses of the vaccine.

But U.S. scientists have said the higher rate of effectiveness came during tests in people aged 55 and under, and was discovered by accident during the clinical trials. Unless otherwise noted, the author is writing in his/her personal capacity.

The meeting, announced on Friday by a US Centres for Disease Control and Prevention (CDC) committee on immunisations, suggests that the Food and Drug Administration (FDA) may be close to authorising distribution of the long-awaited vaccine, at least to those considered most vulnerable.

"With a wide range of vaccine candidates in our portfolio, we should seek approval from our drug regulators, starting with those who will benefit the most and are ready to place a vaccine". The commentaries followed the acknowledgment by AstraZeneca and Oxford University of a production error which raises concerns about preliminary results of their experimental vaccine COVID-19.

The COVID-19 vaccine developed by Oxford and AstraZeneca on Monday was found to be 70% effective on average in a late-stage trial, though questions have circulated about the way the trial was carried out.

Siam Bioscience said that if plans proceed smoothly, Thailand would become the first country in Southeast Asia to produce the vaccine.

But she said it was important to wait for the full data set. "Manufacturers are well-versed in the best way to package products like this", the person added. They will critically assess the data too before advising the government on the safety, quality and effectiveness of any potential vaccine.



Other news